Alpha-Tocopherol
|
Basic information |
| Metabolite name | Alpha-Tocopherol |
 | HMDB0001893 |
 |
C02477 |
 |
14985 |
| Synonyms | alpha tocopherol; |
| No. of studies | 7 |
|
Basic information |
| Metabolite name | Alpha-Tocopherol |
| HMDB0001893 |
|
C02477 |
|
14985 |
| Synonyms | alpha tocopherol; |
| No. of studies | 7 |
|
Relationship between Alpha-Tocopherol and depression (count: 7) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M037 | Type2 | placebo treatment group one-week vs. baseline | Serum | Human | Up |
| Study M037 | Type2 | sertraline treatment group four-week vs. baseline | Serum | Human | Up |
| Study M037 | Type2 | placebo treatment group four-week vs. baseline | Serum | Human | Up |
| Study M045 | Type1 | CUMS group vs. control group | Peripheral blood mononuclear cell | Sprague-Dawley rat | Up |
| Study M087 | Type2 | ketamine group 2-h vs. baseline | Plasma | Human | Down |
| Study M116 | Type3 | ketamine group vs. control group | Hippocampus | Sprague-Dawley rat | Down |
| Study M648 | Type1 | ART-treated HIV with depressive symptom group vs. ART-treated HIV without depressive symptom group, validation cohort | Plasma | Human | Down |
| Study M770 | Type4 | responder group vs. non-responder group | Serum | C57BL/6 mouse | Down |
| Study M953 | Type1 | CRS group vs. control group | Faece | Sprague-Dawley rat | Down |
| Study M953 | Type2 | CRS + Shugan Granule group vs. CRS group | Faece | Sprague-Dawley rat | Up |